Next week at CES, Quellios will be demoing an early prototype of its app.

It’s not a launch. It’s not a product announcement. It’s a checkpoint.

At the center of the demo is Snap and Sense™, Quellios’s patent-pending technology that transforms smartphone videos into physiological signals reflecting the body’s inflammatory response to food.

Inflammation isn’t static. It changes hour to hour — especially in response to what we eat — yet most tools today either ignore that variability or average it away. Quellios focuses on short-term dynamics, because this is where food-related physiological responses are most visible and most often missed. At Quellios, to quell inflammation starts with understanding how individual foods affect the body in the first place.

Over the past few months, Quellios completed a small 20-person test to answer a foundational question:
Do our digital inflammation biomarkers behave like real biology?

Encouragingly, they did:

  • Signals responded predictably to known inflammatory stimuli
  • Measurements were consistent within individuals across repeated readings
  • Results tracked linearly with blood-based markers of oxidative stress and inflammation

This work is early by design. The goal was not to make clinical claims, but to establish biological plausibility and signal behavior under real-world conditions.

Quellios is heading into CES to demo the prototype, gather feedback, and pressure-test real-world usage ahead of its Alpha launch at the end of January.

Media and industry attendees interested in wearables, digital health, food tech, digestive wellness, or body-based sensing are invited to connect with Dr. LeBoeuf, CEO & Co-Founder, for a private walkthrough before or following his live demo at CES 2026.

CES Wearables / Body-Based Tech
Thursday, Jan 8 · 11:00–11:40
Venetian · Level 4 · Lando 4302

Comments

Leave a Reply

Discover more from Quellios

Subscribe now to keep reading and get access to the full archive.

Continue reading